Transplants of adult mesenchymal and neural stem cells provide neuroprotection and behavioral sparing in a transgenic rat model of huntington's disease

Julien Rossignol, Kyle Fink, Kendra Davis, Steven Clerc, Andrew Crane, Jessica Matchynski, Steven Lowrance, Matthew Bombard, Nicholas Dekorver, Laurent Lescaudron, Gary L. Dunbar

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Stem cells have gained significant interest as a potential treatment of neurodegenerative diseases, including Huntington's disease (HD). One source of these cells is adult neural stem cells (aNSCs), which differentiate easily into neuronal lineages. However, these cells are vulnerable to immune responses following transplantation. Another source is bone-marrow-derived mesenchymal stem cells (MSCs), which release neurotrophic factors and anti-inflammatory cytokines following transplantation, and are less vulnerable to rejection. The goal of this study was to compare the efficacy of transplants of MSCs, aNSCs, or cotransplants of MSCs and aNSCs for reducing deficits in a transgenic rat model of HD. HD rats received intrastriatal transplantations of 400,000 MSCs, aNSCs, or a combination of MSCs/aNSCs, while wild-type and HD controls were given vehicle. Rats were tested on the rotarod over the course of 20 weeks. The results indicated that transplants of: (a) aNSCs produced a strong immune response and conferred short-term behavioral benefits; (b) MSCs elicited a relatively weak immune response, and provided a longer term behavioral benefit; and (c) combined MSCs and aNSCs conferred long-term behavioral benefits and increased survival of the transplanted aNSCs. The finding that cotransplanting MSCs with aNSCs can prolong aNSC survival and provide greater behavioral sparing than when the transplants contains only aNSCs suggests that MSCs are capable of creating a more suitable microenvironment for aNSC survival. This cotransplantation strategy may be useful as a future therapeutic option for treating HD, especially if long-term survival of differentiated cells proves to be critically important for preserving lasting functional outcomes.

Original languageEnglish (US)
Pages (from-to)500-509
Number of pages10
JournalStem Cells
Volume32
Issue number2
DOIs
StatePublished - Feb 1 2014
Externally publishedYes

Fingerprint

Transgenic Rats
Adult Stem Cells
Neural Stem Cells
Huntington Disease
Mesenchymal Stromal Cells
Transplants
Cell Survival
Transplantation
Neuroprotection
Nerve Growth Factors
Neurodegenerative Diseases

Keywords

  • Mesenchymal stem cells
  • Neural stem cells
  • Rat model
  • Stem cell microenvironment interactions
  • Stem cell transplantation

ASJC Scopus subject areas

  • Cell Biology
  • Developmental Biology
  • Molecular Medicine

Cite this

Transplants of adult mesenchymal and neural stem cells provide neuroprotection and behavioral sparing in a transgenic rat model of huntington's disease. / Rossignol, Julien; Fink, Kyle; Davis, Kendra; Clerc, Steven; Crane, Andrew; Matchynski, Jessica; Lowrance, Steven; Bombard, Matthew; Dekorver, Nicholas; Lescaudron, Laurent; Dunbar, Gary L.

In: Stem Cells, Vol. 32, No. 2, 01.02.2014, p. 500-509.

Research output: Contribution to journalArticle

Rossignol, J, Fink, K, Davis, K, Clerc, S, Crane, A, Matchynski, J, Lowrance, S, Bombard, M, Dekorver, N, Lescaudron, L & Dunbar, GL 2014, 'Transplants of adult mesenchymal and neural stem cells provide neuroprotection and behavioral sparing in a transgenic rat model of huntington's disease', Stem Cells, vol. 32, no. 2, pp. 500-509. https://doi.org/10.1002/stem.1508
Rossignol, Julien ; Fink, Kyle ; Davis, Kendra ; Clerc, Steven ; Crane, Andrew ; Matchynski, Jessica ; Lowrance, Steven ; Bombard, Matthew ; Dekorver, Nicholas ; Lescaudron, Laurent ; Dunbar, Gary L. / Transplants of adult mesenchymal and neural stem cells provide neuroprotection and behavioral sparing in a transgenic rat model of huntington's disease. In: Stem Cells. 2014 ; Vol. 32, No. 2. pp. 500-509.
@article{9f68fc39b4ec4ead88215d93bb0e3f30,
title = "Transplants of adult mesenchymal and neural stem cells provide neuroprotection and behavioral sparing in a transgenic rat model of huntington's disease",
abstract = "Stem cells have gained significant interest as a potential treatment of neurodegenerative diseases, including Huntington's disease (HD). One source of these cells is adult neural stem cells (aNSCs), which differentiate easily into neuronal lineages. However, these cells are vulnerable to immune responses following transplantation. Another source is bone-marrow-derived mesenchymal stem cells (MSCs), which release neurotrophic factors and anti-inflammatory cytokines following transplantation, and are less vulnerable to rejection. The goal of this study was to compare the efficacy of transplants of MSCs, aNSCs, or cotransplants of MSCs and aNSCs for reducing deficits in a transgenic rat model of HD. HD rats received intrastriatal transplantations of 400,000 MSCs, aNSCs, or a combination of MSCs/aNSCs, while wild-type and HD controls were given vehicle. Rats were tested on the rotarod over the course of 20 weeks. The results indicated that transplants of: (a) aNSCs produced a strong immune response and conferred short-term behavioral benefits; (b) MSCs elicited a relatively weak immune response, and provided a longer term behavioral benefit; and (c) combined MSCs and aNSCs conferred long-term behavioral benefits and increased survival of the transplanted aNSCs. The finding that cotransplanting MSCs with aNSCs can prolong aNSC survival and provide greater behavioral sparing than when the transplants contains only aNSCs suggests that MSCs are capable of creating a more suitable microenvironment for aNSC survival. This cotransplantation strategy may be useful as a future therapeutic option for treating HD, especially if long-term survival of differentiated cells proves to be critically important for preserving lasting functional outcomes.",
keywords = "Mesenchymal stem cells, Neural stem cells, Rat model, Stem cell microenvironment interactions, Stem cell transplantation",
author = "Julien Rossignol and Kyle Fink and Kendra Davis and Steven Clerc and Andrew Crane and Jessica Matchynski and Steven Lowrance and Matthew Bombard and Nicholas Dekorver and Laurent Lescaudron and Dunbar, {Gary L.}",
year = "2014",
month = "2",
day = "1",
doi = "10.1002/stem.1508",
language = "English (US)",
volume = "32",
pages = "500--509",
journal = "Stem Cells",
issn = "1066-5099",
publisher = "AlphaMed Press",
number = "2",

}

TY - JOUR

T1 - Transplants of adult mesenchymal and neural stem cells provide neuroprotection and behavioral sparing in a transgenic rat model of huntington's disease

AU - Rossignol, Julien

AU - Fink, Kyle

AU - Davis, Kendra

AU - Clerc, Steven

AU - Crane, Andrew

AU - Matchynski, Jessica

AU - Lowrance, Steven

AU - Bombard, Matthew

AU - Dekorver, Nicholas

AU - Lescaudron, Laurent

AU - Dunbar, Gary L.

PY - 2014/2/1

Y1 - 2014/2/1

N2 - Stem cells have gained significant interest as a potential treatment of neurodegenerative diseases, including Huntington's disease (HD). One source of these cells is adult neural stem cells (aNSCs), which differentiate easily into neuronal lineages. However, these cells are vulnerable to immune responses following transplantation. Another source is bone-marrow-derived mesenchymal stem cells (MSCs), which release neurotrophic factors and anti-inflammatory cytokines following transplantation, and are less vulnerable to rejection. The goal of this study was to compare the efficacy of transplants of MSCs, aNSCs, or cotransplants of MSCs and aNSCs for reducing deficits in a transgenic rat model of HD. HD rats received intrastriatal transplantations of 400,000 MSCs, aNSCs, or a combination of MSCs/aNSCs, while wild-type and HD controls were given vehicle. Rats were tested on the rotarod over the course of 20 weeks. The results indicated that transplants of: (a) aNSCs produced a strong immune response and conferred short-term behavioral benefits; (b) MSCs elicited a relatively weak immune response, and provided a longer term behavioral benefit; and (c) combined MSCs and aNSCs conferred long-term behavioral benefits and increased survival of the transplanted aNSCs. The finding that cotransplanting MSCs with aNSCs can prolong aNSC survival and provide greater behavioral sparing than when the transplants contains only aNSCs suggests that MSCs are capable of creating a more suitable microenvironment for aNSC survival. This cotransplantation strategy may be useful as a future therapeutic option for treating HD, especially if long-term survival of differentiated cells proves to be critically important for preserving lasting functional outcomes.

AB - Stem cells have gained significant interest as a potential treatment of neurodegenerative diseases, including Huntington's disease (HD). One source of these cells is adult neural stem cells (aNSCs), which differentiate easily into neuronal lineages. However, these cells are vulnerable to immune responses following transplantation. Another source is bone-marrow-derived mesenchymal stem cells (MSCs), which release neurotrophic factors and anti-inflammatory cytokines following transplantation, and are less vulnerable to rejection. The goal of this study was to compare the efficacy of transplants of MSCs, aNSCs, or cotransplants of MSCs and aNSCs for reducing deficits in a transgenic rat model of HD. HD rats received intrastriatal transplantations of 400,000 MSCs, aNSCs, or a combination of MSCs/aNSCs, while wild-type and HD controls were given vehicle. Rats were tested on the rotarod over the course of 20 weeks. The results indicated that transplants of: (a) aNSCs produced a strong immune response and conferred short-term behavioral benefits; (b) MSCs elicited a relatively weak immune response, and provided a longer term behavioral benefit; and (c) combined MSCs and aNSCs conferred long-term behavioral benefits and increased survival of the transplanted aNSCs. The finding that cotransplanting MSCs with aNSCs can prolong aNSC survival and provide greater behavioral sparing than when the transplants contains only aNSCs suggests that MSCs are capable of creating a more suitable microenvironment for aNSC survival. This cotransplantation strategy may be useful as a future therapeutic option for treating HD, especially if long-term survival of differentiated cells proves to be critically important for preserving lasting functional outcomes.

KW - Mesenchymal stem cells

KW - Neural stem cells

KW - Rat model

KW - Stem cell microenvironment interactions

KW - Stem cell transplantation

UR - http://www.scopus.com/inward/record.url?scp=84894515770&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84894515770&partnerID=8YFLogxK

U2 - 10.1002/stem.1508

DO - 10.1002/stem.1508

M3 - Article

VL - 32

SP - 500

EP - 509

JO - Stem Cells

JF - Stem Cells

SN - 1066-5099

IS - 2

ER -